News

Shareholders approved all items on the agenda, including the 2025 annual accounts, as well as the appointment of Jacobo Llanza and Ángel Agudo as members of the Board of Directors. The Meeting […]

Revenue grew by +31%, exceeding guidance, driven by the strength of international markets, both in direct sales and licensing, alongside acquisitions. The Pharma business reached €175 million (+31%), with ophthalmology establishing itself […]

Strong performance across all business areas enabled the company to close the 2025 financial year with organic revenue above guidance and adjusted EBITDA in line with expectations. The Pharma division achieved double-digit […]